Banka Bioloo
Banka Bioloo Q4 FY26 investor presentation: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Banka Bioloo's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.
The short version
For Q4 FY25-26, standalone revenue from operations was ₹1,802.3 Lakhs, a 28.0% increase YoY (from ₹1,408.4 Lakhs in Q4 FY24-25). EBITDA (Standalone, Q4 FY25-26): ₹254.1 Lakh, a turnaround from -₹67.4 Lakh in Q4 FY24-25.
From Banka Bioloo's Q4 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- For Q4 FY25-26, standalone revenue from operations was ₹1,802.3 Lakhs, a 28.0% increase YoY (from ₹1,408.4 Lakhs in Q4 FY24-25).
- Consolidated revenue from operations for Q4 FY25-26 was ₹1,767.5 Lakhs, up 19.1% YoY (from ₹1,483.5 Lakhs in Q4 FY24-25).
- Full-year standalone revenue for FY25-26 was ₹5,975.8 Lakhs, up 8.7% YoY (from ₹5,500.0 Lakhs in FY24-25).
- Full-year consolidated revenue for FY25-26 was ₹5,709.2 Lakhs, a 5.4% increase YoY (from ₹5,417.4 Lakhs in FY24-25).
2 more points from Banka Bioloo's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Banka Bioloo said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points from Banka Bioloo's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Construction
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Banka Bioloo said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Total 12-month order book stands at INR 82 crore.
- Total unexecuted order book is INR 107 crore.
- Banka Railways:
- No new orders received in Q4 FY 25-26.
- 12-month Railways order booking ~INR 26 crore.
- Unexecuted Railway orders stand at ~INR 38 crore year-to-date (YTD).
- Banka WaSH:
- Q4 FY25-26 new orders of ~INR 16 crore, with a strong pipeline under negotiation.
- 12-month total WaSH order booking ~INR 56 crore.
2 more points from Banka Bioloo's call on order book
Pro opens every point from 15K+ earnings calls
Banka Bioloo — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹18 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Banka Bioloo Ltd's management said in earlier quarters
Others in Construction this season
- Current Infraprojects Ltd (Q4 FY26)
Healthy order pipeline of INR 320 crores with a shift back toward Electrical Infrastructure and Utilities sector commanding 54% share. Key concall takeaways…
- K2 Infragen Ltd (Q4 FY26)
500 crore worth of bids are currently pending results, with Rs. Key concall takeaways from K2 Infragen Ltd's Q4 FY26 earnings call — and how it ranks against…
- NBCC (India) Ltd (Q4 FY26)
Q4 FY26 revenue from operations (Consolidated) was ₹4,559.80 Cr, down by 1.75% YoY (Page 10); Standalone Q4 FY26 revenue was ₹4,643.85 Cr, up 21.59% YoY (Page…
- Ganesh Infraworld Ltd (Q4 FY26)
Revenue from Operations for Q4 FY26: ₹229.6 Cr, up 44.7% YoY (Page 9, 29) . Key investor presentation takeaways from Ganesh Infraworld Ltd's Q4 FY26 investor pr
Arthneeti Pro · Annual
Banka Bioloo and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Banka Bioloo Q4 FY26 results?
For Q4 FY25-26, standalone revenue from operations was ₹1,802.3 Lakhs, a 28.0% increase YoY (from ₹1,408.4 Lakhs in Q4 FY24-25). EBITDA (Standalone, Q4 FY25-26): ₹254.1 Lakh, a turnaround from -₹67.4 Lakh in Q4 FY24-25.
What is Banka Bioloo share price analysis?
Banka Bioloo currently shows a neutral. The stock trades at a P/E of 121.1 with a market cap of ₹77 Cr. Investors should review the full earnings analysis for detailed insights.
Is Banka Bioloo planning capital expenditure?
The investor presentation does not explicitly detail specific capex amounts, capacity expansions, or new plant/project timelines.
Keep Banka Bioloo on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.